Completed OBSERVATIONAL NCT00218179

Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1

Prostate, Lung, Colon, and Ovarian Cancer (PLCO) Screen Trial

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Lung Cancer Tobacco Use Disorder

Updated 7 times since 2017 Last updated: Jan 19, 2017 Started: Sep 30, 2005 Primary completion: Dec 31, 2007 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Lung Cancer and Tobacco Use Disorder, this trial is completed. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 7 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Nov 2019 — Jan 2021 [monthly]

Completed
Jun 2018 — Nov 2019 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
University of Minnesota

Data source: University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States